Carisma Therapeutics Funding: $120M Raised, Series B (2021)
Carisma Therapeutics is based in Philadelphia, PA. It has raised $120M in total funding. Latest round: Series B.
Carisma Therapeutics funding overview
Carisma Therapeutics is based in Philadelphia, PA. Carisma Therapeutics has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in March 2021. The round record for Carisma Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include AbbVie Biotech Ventures, Agent Capital, Grazia Equity, HealthCap, IP Group, MRL Ventures Fund and 6 others. 12 distinct backers are named across the disclosed rounds.
Carisma Therapeutics at a glance
Total raised
$120M
Latest round
Series B
Latest round date
March 2021
Headquarters
Philadelphia, PA
Notable investors
AbbVie Biotech Ventures, Agent Capital, Grazia Equity, HealthCap, IP Group, MRL Ventures Fund, Penn Medicine, TPG Biotech
Frequently asked about Carisma Therapeutics funding
How much has Carisma Therapeutics raised?
Carisma Therapeutics has raised $120M in total disclosed funding across the rounds on record.
Who has invested in Carisma Therapeutics?
AbbVie Biotech Ventures, Agent Capital, Grazia Equity, HealthCap, IP Group, MRL Ventures Fund are named among the investors backing Carisma Therapeutics.
What was the latest Carisma Therapeutics funding round?
The most recent disclosed round is a Series B, announced in March 2021.
Where is Carisma Therapeutics based?
Carisma Therapeutics is based in Philadelphia, PA.
When did Carisma Therapeutics last raise?
The last disclosed Carisma Therapeutics round closed in March 2021 at Series B.
Totals shown for Carisma Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Philadelphia and the investors behind them below.
